Faricimab CAS 1607793-29-2

Identification Properties Safety Data Specifications…

Vutrisiran CAS 1867157-35-4

Identification Properties Safety Data Specifications…

D-xylonolactone lactonase;CvXylC CAS 31-1-110 EC:3.1.1.110

D-xylonolactone lactonase;CvXylC,31-1-110,EC:3.1.1.110

guanosine kinase;EaGSK CAS 127-1-73 EC:2.7.1.73 

guanosine kinase;EaGSK,127-1-73,EC:2.7.1.73 

Purine nucleoside phosphorylase ;EaPNP CAS 124-2-13 EC:2.4.2.1

Purine nucleoside phosphorylase ;EaPNP,124-2-13,EC:2.4.2.1

Adenine deaminase;EcAdeD CAS 135-4-21 EC:3.5.4.2

Adenine deaminase;EcAdeD,135-4-21,EC:3.5.4.2

Adenylyl-sulfate kinase;EcCysC CAS 127-1-25 EC:2.7.1.25 

Adenylyl-sulfate kinase;EcCysC,127-1-25,EC:2.7.1.25 

Thymidine phosphorylase;EcDeoA CAS 124-2-41 EC:2.4.2.4

Thymidine phosphorylase;EcDeoA,124-2-41,EC:2.4.2.4

Polyphosphate kinase;RsPPK CAS 27-4-1 1 EC:2.7.4.1 

Polyphosphate kinase;RsPPK,27-4-1 1,EC:2.7.4.1 

Polyphosphate kinase;EcPPK CAS 27-4-12  EC:2.7.4.1 

Polyphosphate kinase;EcPPK,27-4-12 ,EC:2.7.4.1